chr2-165294010-TAA-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The NM_001040142.2(SCN2A):c.-51-1736_-51-1735del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.135 in 149,934 control chromosomes in the GnomAD database, including 354 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.16 ( 283 hom., cov: 0)
Exomes 𝑓: 0.12 ( 71 hom. )
Consequence
SCN2A
NM_001040142.2 intron
NM_001040142.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.311
Genes affected
SCN2A (HGNC:10588): (sodium voltage-gated channel alpha subunit 2) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 2-165294010-TAA-T is Benign according to our data. Variant chr2-165294010-TAA-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 331709.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=2}.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.283 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN2A | NM_001040142.2 | c.-51-1736_-51-1735del | intron_variant | ENST00000375437.7 | NP_001035232.1 | |||
SCN2A | NM_001371246.1 | c.-51-1736_-51-1735del | intron_variant | ENST00000631182.3 | NP_001358175.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.-51-1736_-51-1735del | intron_variant | 5 | NM_001040142.2 | ENSP00000364586 | P1 | |||
SCN2A | ENST00000631182.3 | c.-51-1736_-51-1735del | intron_variant | 5 | NM_001371246.1 | ENSP00000486885 |
Frequencies
GnomAD3 genomes AF: 0.157 AC: 8707AN: 55448Hom.: 283 Cov.: 0
GnomAD3 genomes
AF:
AC:
8707
AN:
55448
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.121 AC: 11468AN: 94476Hom.: 71 AF XY: 0.122 AC XY: 5545AN XY: 45344
GnomAD4 exome
AF:
AC:
11468
AN:
94476
Hom.:
AF XY:
AC XY:
5545
AN XY:
45344
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.157 AC: 8705AN: 55458Hom.: 283 Cov.: 0 AF XY: 0.163 AC XY: 3939AN XY: 24158
GnomAD4 genome
AF:
AC:
8705
AN:
55458
Hom.:
Cov.:
0
AF XY:
AC XY:
3939
AN XY:
24158
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Early Infantile Epileptic Encephalopathy, Autosomal Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Seizures, benign familial infantile, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at